Your browser doesn't support javascript.
loading
A perfusable, vascularized kidney organoid-on-chip model.
Kroll, Katharina T; Homan, Kimberly A; Uzel, Sebastien G M; Mata, Mariana M; Wolf, Kayla J; Rubins, Jonathan E; Lewis, Jennifer A.
Afiliação
  • Kroll KT; Harvard University, Paulson School of Engineering and Applied Sciences, Cambridge, MA, United States of America.
  • Homan KA; Wyss Institute for Biologically Inspired Engineering, Boston, MA, United States of America.
  • Uzel SGM; Complex in vitro Systems, Safety Assessment, Genentech Inc, South San Francisco, CA, United States of America.
  • Mata MM; Complex in vitro Systems, Safety Assessment, Genentech Inc, South San Francisco, CA, United States of America.
  • Wolf KJ; Harvard University, Paulson School of Engineering and Applied Sciences, Cambridge, MA, United States of America.
  • Rubins JE; Wyss Institute for Biologically Inspired Engineering, Boston, MA, United States of America.
  • Lewis JA; Harvard University, Paulson School of Engineering and Applied Sciences, Cambridge, MA, United States of America.
Biofabrication ; 16(4)2024 Jul 05.
Article em En | MEDLINE | ID: mdl-38906132
ABSTRACT
The ability to controllably perfuse kidney organoids would better recapitulate the native tissue microenvironment for applications ranging from drug testing to therapeutic use. Here, we report a perfusable, vascularized kidney organoid on chip model composed of two individually addressable channels embedded in an extracellular matrix (ECM). The channels are respectively seeded with kidney organoids and human umbilical vein endothelial cells that form a confluent endothelium (macrovessel). During perfusion, endogenous endothelial cells present within the kidney organoids migrate through the ECM towards the macrovessel, where they form lumen-on-lumen anastomoses that are supported by stromal-like cells. Once micro-macrovessel integration is achieved, we introduced fluorescently labeled dextran of varying molecular weight and red blood cells into the macrovessel, which are transported through the microvascular network to the glomerular epithelia within the kidney organoids. Our approach for achieving controlled organoid perfusion opens new avenues for generating other perfused human tissues.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article